A detailed history of Iron Horse Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Iron Horse Wealth Management, LLC holds 117 shares of ABBV stock, worth $19,930. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117
Previous 72 62.5%
Holding current value
$19,930
Previous $12,000 91.67%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $7,372 - $8,969
45 Added 62.5%
117 $23,000
Q1 2024

Apr 17, 2024

BUY
$159.82 - $182.1 $7,191 - $8,194
45 Added 166.67%
72 $13,000
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $2,271 - $2,629
17 Added 170.0%
27 $4,000
Q4 2022

Jan 19, 2023

BUY
$138.31 - $165.87 $1,383 - $1,658
10 New
10 $2,000
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $6,943 - $7,735
66 Added 660.0%
76 $9,000
Q4 2020

Jan 14, 2021

BUY
$80.49 - $108.67 $804 - $1,086
10 New
10 $1,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Iron Horse Wealth Management, LLC Portfolio

Follow Iron Horse Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Horse Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Horse Wealth Management, LLC with notifications on news.